"{\"data\":[{\"id\":\"3822665\",\"type\":\"news\",\"attributes\":{\"publishOn\":\"2022-04-12T09:05:29-04:00\",\"isLockedPro\":false,\"commentCount\":0,\"gettyImageUrl\":\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1227365805/image_1227365805.jpg\",\"themes\":{\"m-a\":{\"path\":\"/market-news/m-a\",\"slug\":\"m-a\",\"title\":\"M&A\",\"sasource\":\"theme_breadcrumb\",\"non_theme\":false},\"technology\":{\"path\":\"/market-news/technology\",\"slug\":\"technology\",\"title\":\"Tech\",\"sasource\":\"theme_breadcrumb\",\"non_theme\":false},\"large-cap\":{\"path\":\"/\",\"slug\":\"large-cap\",\"title\":null,\"sasource\":\"\",\"non_theme\":true}},\"title\":\"KKR said near $4B deal to purchase Barracuda Networks from Thoma Bravo\",\"lastModified\":\"2022-04-12T09:05:30-04:00\",\"isExclusive\":false,\"status\":\"Active\",\"content\":\"<p><figure class=\\\"getty-figure\\\" data-type=\\\"getty-image\\\">                     <picture>                         <img src=\\\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1227365805/image_1227365805.jpg?io=getty-c-w750\\\" alt=\\\"Person holding tablet, business concept\\\" data-id=\\\"1227365805\\\" data-type=\\\"getty-image\\\" width=\\\"1536px\\\" height=\\\"810px\\\" srcset=\\\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1227365805/image_1227365805.jpg?io=getty-c-w1536 1536w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1227365805/image_1227365805.jpg?io=getty-c-w1280 1280w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1227365805/image_1227365805.jpg?io=getty-c-w1080 1080w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1227365805/image_1227365805.jpg?io=getty-c-w750 750w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1227365805/image_1227365805.jpg?io=getty-c-w640 640w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1227365805/image_1227365805.jpg?io=getty-c-w480 480w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1227365805/image_1227365805.jpg?io=getty-c-w320 320w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1227365805/image_1227365805.jpg?io=getty-c-w240 240w\\\">                     </picture>                                          <figcaption class=\\\"caption\\\" data-type=\\\"getty-image\\\"><p>ra2studio/iStock via Getty Images</p></figcaption>                 </figure></p>\\n<ul>\\n<li>KKR (<span class=\\\"ticker-hover-wrapper\\\">NYSE:<a href=\\\"https://seekingalpha.com/symbol/KKR\\\" title=\\\"KKR &amp; Co. Inc.\\\">KKR</a></span>) is said to be close to a deal to acquire Barracuda Networks from private equity firm Thoma Bravo for $4 billion, according to a Reuters report.</li>\\n<li>Thoma Bravo agreed to buy Barracuda Networks<a href=\\\"https://seekingalpha.com/amp/news/3314452-barracuda-networks-plus-15_7-percent-on-1_6b-go-private-deal\\\" target=\\\"_blank\\\"> for $1.6 billion </a>in late November 2017.</li>\\n<li>The news comes after cybersecurity firm SailPoint agreed to be acquired by Thoma Bravo in<a href=\\\"https://seekingalpha.com/news/3822232-cybersecurity-firm-sailpoint-to-be-acquired-by-thoma-bravo-in-69b-deal\\\" target=\\\"_blank\\\"> $6.9B deal on Monday.</a>\\n</li>\\n</ul>\",\"metered\":false,\"correctionReason\":null},\"relationships\":{\"author\":{\"data\":{\"id\":\"52996117\",\"type\":\"newsAuthorUser\"}},\"sentiments\":{\"data\":[]},\"primaryTickers\":{\"data\":[{\"id\":\"8319\",\"type\":\"tag\"}]},\"secondaryTickers\":{\"data\":[]},\"otherTags\":{\"data\":[]},\"ratingChangeNotice\":{}},\"links\":{\"self\":\"/news/3822665-kkr-said-near-4b-deal-to-purchase-barracuda-networks-from-thoma-bravo\",\"canonical\":\"https://seekingalpha.com/news/3822665-kkr-said-near-4b-deal-to-purchase-barracuda-networks-from-thoma-bravo\",\"uriImage\":\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1227365805/image_1227365805.jpg?io=getty-c-w750\",\"schemaImage\":[\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1227365805/image_1227365805.jpg?io=getty-c-w1280\",\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1227365805/image_1227365805.jpg?io=getty-c-crop-16-9\",\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1227365805/image_1227365805.jpg?io=getty-c-crop-4-3\"]}},{\"id\":\"3822664\",\"type\":\"news\",\"attributes\":{\"publishOn\":\"2022-04-12T09:04:10-04:00\",\"isLockedPro\":false,\"commentCount\":0,\"gettyImageUrl\":null,\"themes\":{\"financials\":{\"path\":\"/market-news/financials\",\"slug\":\"financials\",\"title\":\"Financials\u00a0\",\"sasource\":\"theme_breadcrumb\",\"non_theme\":false},\"news-metered\":{\"path\":\"/\",\"slug\":\"news-metered\",\"title\":null,\"sasource\":\"\",\"non_theme\":true},\"large-cap\":{\"path\":\"/\",\"slug\":\"large-cap\",\"title\":null,\"sasource\":\"\",\"non_theme\":true}},\"title\":\"Chinese banks extend lead as the world's biggest banks in 2021\",\"lastModified\":\"2022-04-12T09:04:10-04:00\",\"isExclusive\":false,\"status\":\"Active\",\"content\":\"<ul> <li>Chinese banks<a href=\\\"https://seekingalpha.com/pr/18745484-s-and-p-global-market-intelligence-global-bank-rankings-european-banks-slid-down-rankings\\\" target=\\\"_blank\\\"> increased their lead</a> as the biggest financial institutions in the world in 2021 and U.S. banks also improved their<span class=\\\"paywall-full-content\\\"> rankings while many European banks lost ground, according to S&amp;P Global Market Intelligence's annual ranking of the 100 largest banks in terms of total assets.</span> </li> <li class=\\\"paywall-full-content\\\">Twenty-six of the 37 European lenders on the list fell in ranking by between one and nine notches from a year earlier. Total assets of all European banks on the list shrank by 2.16% to $36.9T in 2021 from $37.7T a year earlier.</li> <li class=\\\"paywall-full-content\\\">\\\"European lenders saw their balance sheets shrink as their home markets offered slower economic growth relative to the rest of the world,\\\" said Nathan Stovall, principal analyst at S&amp;P Global Market Intelligence. \\\"Several European lenders also scaled back their stateside operations after facing strong competition from major U.S. lenders.\\\"</li> <li class=\\\"paywall-full-content\\\">For example, Spain's Banco Bilbao Vizcaya Argentaria (<a href=\\\"https://seekingalpha.com/symbol/BBVA\\\" title=\\\"Banco Bilbao Vizcaya Argentaria, S.A.\\\">BBVA</a>) fell one spot to No. 47<a href=\\\"https://seekingalpha.com/news/3636412-pnc-to-acquire-u-s-operations-of-spains-bbva-for-11_6b\\\" target=\\\"_blank\\\"> after selling its 639-branch business</a> in the U.S. with almost $103B in total assets to PNC Financial (<a href=\\\"https://seekingalpha.com/symbol/PNC\\\" title=\\\"The PNC Financial Services Group, Inc.\\\">PNC</a>).</li> <li class=\\\"paywall-full-content\\\">Industrial &amp; Commercial Bank of China (<a href=\\\"https://seekingalpha.com/symbol/IDCBY\\\" title=\\\"Industrial &amp; Commercial Bank of China Ltd.\\\">OTCPK:IDCBY</a>) (<a href=\\\"https://seekingalpha.com/symbol/IDCBF\\\" title=\\\"Industrial &amp; Commercial Bank of China Ltd.\\\">OTCPK:IDCBF</a>), China Construction Bank (<a href=\\\"https://seekingalpha.com/symbol/CICHY\\\" title=\\\"China Construction Bank Corporation\\\">OTCPK:CICHY</a>) (<a href=\\\"https://seekingalpha.com/symbol/CICHF\\\" title=\\\"China Construction Bank Corporation\\\">OTCPK:CICHF</a>), Agricultural Bank of China (<a href=\\\"https://seekingalpha.com/symbol/ACGBY\\\" title=\\\"Agricultural Bank of China Limited\\\">OTCPK:ACGBY</a>) (<a href=\\\"https://seekingalpha.com/symbol/ACGBF\\\" title=\\\"Agricultural Bank of China Limited\\\">OTCPK:ACGBF</a>), and Bank of China (<a href=\\\"https://seekingalpha.com/symbol/BACHF\\\" title=\\\"Bank of China Limited\\\">OTCPK:BACHF</a>) (<a href=\\\"https://seekingalpha.com/symbol/BACHY\\\" title=\\\"Bank of China Limited\\\">OTCPK:BACHY</a>) held on to their top four positions with expanded balance sheets, widening their lead.</li> <li class=\\\"paywall-full-content\\\">Among U.S. banks, JPMorgan Chase (<a href=\\\"https://seekingalpha.com/symbol/JPM\\\" title=\\\"JPMorgan Chase &amp; Co.\\\">JPM</a>), Bank of America (<a href=\\\"https://seekingalpha.com/symbol/BAC\\\" title=\\\"Bank of America Corporation\\\">BAC</a>), and Goldman Sachs (<a href=\\\"https://seekingalpha.com/symbol/GS\\\" title=\\\"The Goldman Sachs Group, Inc.\\\">GS</a>) saw balance sheet growth in 2021. JPMorgan (<a href=\\\"https://seekingalpha.com/symbol/JPM\\\" title=\\\"JPMorgan Chase &amp; Co.\\\">JPM</a>) rose one notch to No. 5 and Bank of America (<a href=\\\"https://seekingalpha.com/symbol/BAC\\\" title=\\\"Bank of America Corporation\\\">BAC</a>) improved by two spots to No. 7.</li> <li class=\\\"paywall-full-content\\\">\\\"Government efforts to mitigate the economic impact of the pandemic flooded the markets with liquidity and inflated U.S. bank balance sheets,\\\" Stovall said. \\\"The absence of government stimulus and the Fed's efforts to combat elevated inflation, including through the reduction of its $9T balance sheet, will lead to slower balance sheet growth in the future.\\\"</li> </ul>\",\"metered\":true,\"correctionReason\":null},\"relationships\":{\"author\":{\"data\":{\"id\":\"49447318\",\"type\":\"newsAuthorUser\"}},\"sentiments\":{\"data\":[]},\"primaryTickers\":{\"data\":[{\"id\":\"11467\",\"type\":\"tag\"}]},\"secondaryTickers\":{\"data\":[{\"id\":\"15544\",\"type\":\"tag\"},{\"id\":\"14736\",\"type\":\"tag\"},{\"id\":\"19749\",\"type\":\"tag\"},{\"id\":\"19750\",\"type\":\"tag\"},{\"id\":\"16040\",\"type\":\"tag\"},{\"id\":\"14637\",\"type\":\"tag\"},{\"id\":\"26230\",\"type\":\"tag\"},{\"id\":\"935\",\"type\":\"tag\"},{\"id\":\"906\",\"type\":\"tag\"},{\"id\":\"907\",\"type\":\"tag\"},{\"id\":\"3936\",\"type\":\"tag\"},{\"id\":\"4974\",\"type\":\"tag\"}]},\"otherTags\":{\"data\":[]},\"ratingChangeNotice\":{}},\"links\":{\"self\":\"/news/3822664-chinese-banks-extend-lead-as-the-worlds-biggest-banks-in-2021\",\"canonical\":\"https://seekingalpha.com/news/3822664-chinese-banks-extend-lead-as-the-worlds-biggest-banks-in-2021\",\"uriImage\":\"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png\",\"schemaImage\":{\"@type\":\"ImageObject\",\"url\":\"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png\"}}},{\"id\":\"3822663\",\"type\":\"news\",\"attributes\":{\"publishOn\":\"2022-04-12T09:04:07-04:00\",\"isLockedPro\":false,\"commentCount\":0,\"gettyImageUrl\":\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/534306725/image_534306725.jpg\",\"themes\":{\"consumer\":{\"path\":\"/market-news/consumer\",\"slug\":\"consumer\",\"title\":\"Consumer\u00a0\",\"sasource\":\"theme_breadcrumb\",\"non_theme\":false},\"news-metered\":{\"path\":\"/\",\"slug\":\"news-metered\",\"title\":null,\"sasource\":\"\",\"non_theme\":true},\"small-cap\":{\"path\":\"/\",\"slug\":\"small-cap\",\"title\":null,\"sasource\":\"\",\"non_theme\":true}},\"title\":\"Guess plays defense against Legion accusations again\",\"lastModified\":\"2022-04-12T09:04:14-04:00\",\"isExclusive\":false,\"status\":\"Active\",\"content\":\"<p><figure class=\\\"getty-figure\\\" data-type=\\\"getty-image\\\"> <picture> <img src=\\\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/534306725/image_534306725.jpg?io=getty-c-w750\\\" alt=\\\"3D men sitting at a table and having business meeting\\\" data-id=\\\"534306725\\\" data-type=\\\"getty-image\\\" width=\\\"1536px\\\" height=\\\"1152px\\\" srcset=\\\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/534306725/image_534306725.jpg?io=getty-c-w1536 1536w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/534306725/image_534306725.jpg?io=getty-c-w1280 1280w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/534306725/image_534306725.jpg?io=getty-c-w1080 1080w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/534306725/image_534306725.jpg?io=getty-c-w750 750w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/534306725/image_534306725.jpg?io=getty-c-w640 640w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/534306725/image_534306725.jpg?io=getty-c-w480 480w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/534306725/image_534306725.jpg?io=getty-c-w320 320w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/534306725/image_534306725.jpg?io=getty-c-w240 240w\\\"> </picture> <figcaption class=\\\"caption\\\" data-type=\\\"getty-image\\\"><p>Lpstudio/iStock via Getty Images</p></figcaption> </figure></p> <ul> <li>Guess (<span class=\\\"ticker-hover-wrapper\\\">NYSE:<a href=\\\"https://seekingalpha.com/symbol/GES\\\" title=\\\"Guess', Inc.\\\">GES</a></span>) posted a new letter in response to allegations from Legion Partners on the<span class=\\\"paywall-full-content\\\"> mishandling of sexual assault allegations against co-founder Paul Marciano.</span> </li> <li class=\\\"paywall-full-content\\\">The company stated that Legion seems bent on recycling false and misleading information, while it remains focused on executing its transformation strategy and driving our strong business performance.</li> <li class=\\\"paywall-full-content\\\">The Guess board established a special committee to conduct a comprehensive investigation into Marciano, the findings of which were made public.</li> <li class=\\\"paywall-full-content\\\">Legion is said to be also be misrepresenting the reason why Guess is holding its annual meeting on April 22. The board communicated to Legion that the earlier annual meeting date was also set to minimize the disruption and management distraction being caused by Legion\u2019s campaign.</li> <li class=\\\"paywall-full-content\\\">Dig through the <a href=\\\"https://seekingalpha.com/news/3814672-guess-pops-up-after-margins-expansion-in-q4-earnings-results\\\" target=\\\"_blank\\\">summary of Guess' last earnings report.</a> </li> </ul>\",\"metered\":true,\"correctionReason\":null},\"relationships\":{\"author\":{\"data\":{\"id\":\"954720\",\"type\":\"newsAuthorUser\"}},\"sentiments\":{\"data\":[]},\"primaryTickers\":{\"data\":[{\"id\":\"2977\",\"type\":\"tag\"}]},\"secondaryTickers\":{\"data\":[]},\"otherTags\":{\"data\":[]},\"ratingChangeNotice\":{}},\"links\":{\"self\":\"/news/3822663-guess-plays-defense-against-legion-accusations-again\",\"canonical\":\"https://seekingalpha.com/news/3822663-guess-plays-defense-against-legion-accusations-again\",\"uriImage\":\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/534306725/image_534306725.jpg?io=getty-c-w750\",\"schemaImage\":[\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/534306725/image_534306725.jpg?io=getty-c-w1280\",\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/534306725/image_534306725.jpg?io=getty-c-crop-16-9\",\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/534306725/image_534306725.jpg?io=getty-c-crop-4-3\"]}},{\"id\":\"3822662\",\"type\":\"news\",\"attributes\":{\"publishOn\":\"2022-04-12T09:01:56-04:00\",\"isLockedPro\":false,\"commentCount\":0,\"gettyImageUrl\":null,\"themes\":{\"micro-cap\":{\"path\":\"/\",\"slug\":\"micro-cap\",\"title\":null,\"sasource\":\"\",\"non_theme\":true}},\"title\":\"IDGlobal announces sales and marketing agreement with supplier of crypto mining rigs\",\"lastModified\":\"2022-04-12T09:01:56-04:00\",\"isExclusive\":false,\"status\":\"Active\",\"content\":\"<ul>\\n<li><p>IDGlobal (<span class=\\\"ticker-hover-wrapper\\\"><a href=\\\"https://seekingalpha.com/symbol/IDGC\\\" title=\\\"ID Global Corporation\\\">OTCPK:IDGC</a></span>)\u00a0<a href=\\\"https://seekingalpha.com/pr/18746124-azure-blockchain-inc-wholly-owned-subsidiary-of-idglobal-corp-announces-sales-and-marketing\\\" target=\\\"_blank\\\">announces new business plan</a>, has launched the procurement of a variety of crypto mining rigs.</p></li>\\n<li><p>The company CEO,\u00a0Sebastien C. DuFort\u00a0stated \\\"The company is excited about the first development of many to come.\\\"</p></li>\\n</ul>\",\"metered\":false,\"correctionReason\":null},\"relationships\":{\"author\":{\"data\":{\"id\":\"51785401\",\"type\":\"newsAuthorUser\"}},\"sentiments\":{\"data\":[]},\"primaryTickers\":{\"data\":[{\"id\":\"26235\",\"type\":\"tag\"}]},\"secondaryTickers\":{\"data\":[]},\"otherTags\":{\"data\":[]},\"ratingChangeNotice\":{}},\"links\":{\"self\":\"/news/3822662-idglobal-announces-sales-and-marketing-agreement-with-supplier-of-crypto-mining-rigs\",\"canonical\":\"https://seekingalpha.com/news/3822662-idglobal-announces-sales-and-marketing-agreement-with-supplier-of-crypto-mining-rigs\",\"uriImage\":\"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png\",\"schemaImage\":{\"@type\":\"ImageObject\",\"url\":\"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png\"}}},{\"id\":\"3822661\",\"type\":\"news\",\"attributes\":{\"publishOn\":\"2022-04-12T09:01:23-04:00\",\"isLockedPro\":false,\"commentCount\":0,\"gettyImageUrl\":\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293773576/image_1293773576.jpg\",\"themes\":{\"healthcare\":{\"path\":\"/market-news/healthcare\",\"slug\":\"healthcare\",\"title\":\"Healthcare\u00a0\",\"sasource\":\"theme_breadcrumb\",\"non_theme\":false},\"news-metered\":{\"path\":\"/\",\"slug\":\"news-metered\",\"title\":null,\"sasource\":\"\",\"non_theme\":true},\"small-cap\":{\"path\":\"/\",\"slug\":\"small-cap\",\"title\":null,\"sasource\":\"\",\"non_theme\":true}},\"title\":\"VistaGen, AffaMed plan to start global study of nasal spray PH94B for anxiety in H2\",\"lastModified\":\"2022-04-12T09:01:24-04:00\",\"isExclusive\":false,\"status\":\"Active\",\"content\":\"<p><figure class=\\\"getty-figure\\\" data-type=\\\"getty-image\\\"> <picture> <img src=\\\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293773576/image_1293773576.jpg?io=getty-c-w750\\\" alt=\\\"Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research. Working on Computers, Analyzing Samples\\\" data-id=\\\"1293773576\\\" data-type=\\\"getty-image\\\" width=\\\"1536px\\\" height=\\\"1536px\\\" srcset=\\\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293773576/image_1293773576.jpg?io=getty-c-w1536 1536w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293773576/image_1293773576.jpg?io=getty-c-w1280 1280w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293773576/image_1293773576.jpg?io=getty-c-w1080 1080w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293773576/image_1293773576.jpg?io=getty-c-w750 750w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293773576/image_1293773576.jpg?io=getty-c-w640 640w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293773576/image_1293773576.jpg?io=getty-c-w480 480w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293773576/image_1293773576.jpg?io=getty-c-w320 320w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293773576/image_1293773576.jpg?io=getty-c-w240 240w\\\"> </picture> <figcaption class=\\\"caption\\\" data-type=\\\"getty-image\\\"><p>gorodenkoff/iStock via Getty Images</p></figcaption> </figure></p> <ul> <li>VistaGen Therapeutics (<span class=\\\"ticker-hover-wrapper\\\">NASDAQ:<a href=\\\"https://seekingalpha.com/symbol/VTGN\\\" title=\\\"VistaGen Therapeutics, Inc.\\\">VTGN</a></span>) and AffaMed Therapeutics <a href=\\\"https://seekingalpha.com/pr/18745761-vistagen-and-affamed-complete-key-regulatory-submissions-for-palisade-global-phase-3-clinical\\\" target=\\\"_blank\\\">said</a> they have completed regulatory preparations to<span class=\\\"paywall-full-content\\\"> begin a phase 3 trial of VistaGen\u2019s nasal spray PH94B (AM005) for the acute treatment of anxiety in adults with social anxiety disorder (SAD), in the U.S. and China.</span> </li> <li class=\\\"paywall-full-content\\\">The company said the main purpose of the Phase 3 study, dubbed PALISADE Global, is to support potential commercialization of PH94B in China and other markets outside of the U.S. The design of the PALISADE Global study is based on ongoing phase 3 trials, PALISADE-1 and PALISADE-2, of PH94B in the U.S.</li> <li class=\\\"paywall-full-content\\\">VistaGen said its recent submission of the PALISADE Global study protocol to the U.S. Food and Drug Administration (FDA) under its existing application for a trial of PH94B in SAD and AffaMed getting regulatory clearance of an application for a trial in China for the drug has cleared the way to begin PALISADE Global in the U.S. and China during H2 2022.</li> <li class=\\\"paywall-full-content\\\">The companies also expect to begin this phase 3 study in Canada, Mexico, and South Korea.</li> </ul>\",\"metered\":true,\"correctionReason\":null},\"relationships\":{\"author\":{\"data\":{\"id\":\"54324280\",\"type\":\"newsAuthorUser\"}},\"sentiments\":{\"data\":[]},\"primaryTickers\":{\"data\":[{\"id\":\"35310\",\"type\":\"tag\"}]},\"secondaryTickers\":{\"data\":[]},\"otherTags\":{\"data\":[]},\"ratingChangeNotice\":{}},\"links\":{\"self\":\"/news/3822661-vistagen-affamed-plan-to-start-global-study-of-nasal-spray-ph94b-for-anxiety-in-h2\",\"canonical\":\"https://seekingalpha.com/news/3822661-vistagen-affamed-plan-to-start-global-study-of-nasal-spray-ph94b-for-anxiety-in-h2\",\"uriImage\":\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293773576/image_1293773576.jpg?io=getty-c-w750\",\"schemaImage\":[\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293773576/image_1293773576.jpg?io=getty-c-w1280\",\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293773576/image_1293773576.jpg?io=getty-c-crop-16-9\",\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293773576/image_1293773576.jpg?io=getty-c-crop-4-3\"]}},{\"id\":\"3822655\",\"type\":\"news\",\"attributes\":{\"publishOn\":\"2022-04-12T08:56:09-04:00\",\"isLockedPro\":false,\"commentCount\":0,\"gettyImageUrl\":null,\"themes\":{\"financials\":{\"path\":\"/market-news/financials\",\"slug\":\"financials\",\"title\":\"Financials\u00a0\",\"sasource\":\"theme_breadcrumb\",\"non_theme\":false},\"large-cap\":{\"path\":\"/\",\"slug\":\"large-cap\",\"title\":null,\"sasource\":\"\",\"non_theme\":true}},\"title\":\"T. Rowe Price reports MOM rise in AUM\",\"lastModified\":\"2022-04-12T08:56:09-04:00\",\"isExclusive\":false,\"status\":\"Active\",\"content\":\"<ul> <li>Investment management firm, T. Rowe Price\u00a0(<span class=\\\"ticker-hover-wrapper\\\">NASDAQ:<a href=\\\"https://seekingalpha.com/symbol/TROW\\\" title=\\\"T. Rowe Price Group, Inc.\\\">TROW</a></span>) <a href=\\\"https://seekingalpha.com/pr/18746252-t-rowe-price-group-reports-preliminary-month-end-assets-under-management-for-march-2022\\\" target=\\\"_blank\\\">reported</a> AUM of $1.55T as of March\u00a031, 2022, up from $1.54T as of February 28, 2022.</li>\\n<li>Client transfers from mutual funds to other portfolios, including trusts and separate accounts, stood at $0.5B in March 2022 and $4.1B for the quarter ended March\u00a031, 2022.</li>\\n</ul>\",\"metered\":false,\"correctionReason\":null},\"relationships\":{\"author\":{\"data\":{\"id\":\"56260577\",\"type\":\"newsAuthorUser\"}},\"sentiments\":{\"data\":[]},\"primaryTickers\":{\"data\":[{\"id\":\"3390\",\"type\":\"tag\"}]},\"secondaryTickers\":{\"data\":[]},\"otherTags\":{\"data\":[]},\"ratingChangeNotice\":{}},\"links\":{\"self\":\"/news/3822655-t-rowe-price-reports-mom-rise-in-aum\",\"canonical\":\"https://seekingalpha.com/news/3822655-t-rowe-price-reports-mom-rise-in-aum\",\"uriImage\":\"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png\",\"schemaImage\":{\"@type\":\"ImageObject\",\"url\":\"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png\"}}},{\"id\":\"3822660\",\"type\":\"news\",\"attributes\":{\"publishOn\":\"2022-04-12T08:55:23-04:00\",\"isLockedPro\":false,\"commentCount\":0,\"gettyImageUrl\":null,\"themes\":{\"healthcare\":{\"path\":\"/market-news/healthcare\",\"slug\":\"healthcare\",\"title\":\"Healthcare\u00a0\",\"sasource\":\"theme_breadcrumb\",\"non_theme\":false},\"news-metered\":{\"path\":\"/\",\"slug\":\"news-metered\",\"title\":null,\"sasource\":\"\",\"non_theme\":true},\"micro-cap\":{\"path\":\"/\",\"slug\":\"micro-cap\",\"title\":null,\"sasource\":\"\",\"non_theme\":true}},\"title\":\"Cyclacel Pharmaceuticals jumps on preclinical data for blood cancer treatment fadraciclib\",\"lastModified\":\"2022-04-12T08:55:23-04:00\",\"isExclusive\":false,\"status\":\"Active\",\"content\":\"<ul> <li>Shares of biopharmaceutical company Cyclacel Pharmaceuticals (<span class=\\\"ticker-hover-wrapper\\\">NASDAQ:<a href=\\\"https://seekingalpha.com/symbol/CYCC\\\" title=\\\"Cyclacel Pharmaceuticals, Inc.\\\">CYCC</a></span>) have added 13.2% in premarket trading on Tuesday after <a href=\\\"https://seekingalpha.com/pr/18745729-cyclacel-pharmaceuticals-announces-publication-confirming-fadraciclib-suppresses-mcl1-and\\\" target=\\\"_blank\\\">announcing</a> publication<span class=\\\"paywall-full-content\\\"> of preclinical data confirming that its CDK2/9 inhibitor fadraciclib suppresses the protein MCL1 and synergizes with oral therapy venetoclax in the treatment of chronic lymphocytic leukemia.</span> </li> <li class=\\\"paywall-full-content\\\">Publication announced in the journal <em>Leukemia.</em> </li> <li class=\\\"paywall-full-content\\\">Results from the study confirmed that fadraciclib reduced levels of the short-lived anti-apoptotic protein MCL1 and induced apoptosis in primary chronic lymphocytic leukemia cells.</li> <li class=\\\"paywall-full-content\\\">Fadraciclib was also shown to combine synergistically with venetoclax, the only FDA-approved apoptosis enabling, leukemia treatment.</li> <li class=\\\"paywall-full-content\\\">The data supports the rationale for pursuing clinical development of fadraciclib, either alone or in combination with a BCL2 antagonist, for the treatment of chronic lymphocytic leukemia.</li> </ul>\",\"metered\":true,\"correctionReason\":null},\"relationships\":{\"author\":{\"data\":{\"id\":\"56228617\",\"type\":\"newsAuthorUser\"}},\"sentiments\":{\"data\":[]},\"primaryTickers\":{\"data\":[{\"id\":\"7350\",\"type\":\"tag\"}]},\"secondaryTickers\":{\"data\":[]},\"otherTags\":{\"data\":[]},\"ratingChangeNotice\":{}},\"links\":{\"self\":\"/news/3822660-cyclacel-pharmaceuticals-jumps-on-preclinical-data-for-blood-cancer-treatment-fadraciclib\",\"canonical\":\"https://seekingalpha.com/news/3822660-cyclacel-pharmaceuticals-jumps-on-preclinical-data-for-blood-cancer-treatment-fadraciclib\",\"uriImage\":\"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png\",\"schemaImage\":{\"@type\":\"ImageObject\",\"url\":\"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png\"}}},{\"id\":\"3822658\",\"type\":\"news\",\"attributes\":{\"publishOn\":\"2022-04-12T08:54:29-04:00\",\"isLockedPro\":false,\"commentCount\":0,\"gettyImageUrl\":null,\"themes\":{\"guidance\":{\"path\":\"/\",\"slug\":\"guidance\",\"title\":null,\"sasource\":\"\",\"non_theme\":true},\"news-metered\":{\"path\":\"/\",\"slug\":\"news-metered\",\"title\":null,\"sasource\":\"\",\"non_theme\":true},\"micro-cap\":{\"path\":\"/\",\"slug\":\"micro-cap\",\"title\":null,\"sasource\":\"\",\"non_theme\":true}},\"title\":\"Healthy Extracts expects Q1 net revenue growth of 187% to record $489K\",\"lastModified\":\"2022-04-12T08:54:29-04:00\",\"isExclusive\":false,\"status\":\"Active\",\"content\":\"<ul> <li>Healthy Extracts (<span class=\\\"ticker-hover-wrapper\\\"><a href=\\\"https://seekingalpha.com/symbol/HYEX\\\" title=\\\"Healthy Extracts Inc.\\\">OTCQB:HYEX</a></span>) <a href=\\\"https://seekingalpha.com/pr/18746272-healthy-extracts-expects-q1-2022-net-revenue-up-187-percent-to-record-489000-driving-first\\\" target=\\\"_blank\\\">expects</a> Q1 net revenue to be up 187% Y/Y to more than $489K and guides a first<span class=\\\"paywall-full-content\\\"> profitable quarter.</span> </li> <li class=\\\"paywall-full-content\\\">The company is on track for revenue to double to more than $3M in fiscal year.</li> <li class=\\\"paywall-full-content\\\">\u201cOur record top-line for a first quarter resulted primarily from expansion of direct-to-consumer channels, including a four-fold increase in recurring revenue from product subscriptions,\u201d stated Duke Pitts, president of Healthy Extracts. \u201cWe also expect this strong performance to drive our first-ever positive net income quarter. We believe the progress we have made, particularly with expanding our sales channels and portfolio of clinically proven natural products, keeps us on course for our earlier guided 100% sales growth in 2022. Together with our continued focus on building our recurring revenue stream from subscriptions, we anticipate a continued strengthening of our shareholder value throughout the year.\\\"</li> </ul>\",\"metered\":true,\"correctionReason\":null},\"relationships\":{\"author\":{\"data\":{\"id\":\"32439325\",\"type\":\"newsAuthorUser\"}},\"sentiments\":{\"data\":[]},\"primaryTickers\":{\"data\":[{\"id\":\"584075\",\"type\":\"tag\"}]},\"secondaryTickers\":{\"data\":[]},\"otherTags\":{\"data\":[]},\"ratingChangeNotice\":{}},\"links\":{\"self\":\"/news/3822658-healthy-extracts-expects-q1-net-revenue-growth-of-187-to-record-489k\",\"canonical\":\"https://seekingalpha.com/news/3822658-healthy-extracts-expects-q1-net-revenue-growth-of-187-to-record-489k\",\"uriImage\":\"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png\",\"schemaImage\":{\"@type\":\"ImageObject\",\"url\":\"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png\"}}},{\"id\":\"3822657\",\"type\":\"news\",\"attributes\":{\"publishOn\":\"2022-04-12T08:54:13-04:00\",\"isLockedPro\":false,\"commentCount\":0,\"gettyImageUrl\":null,\"themes\":{\"news-metered\":{\"path\":\"/\",\"slug\":\"news-metered\",\"title\":null,\"sasource\":\"\",\"non_theme\":true},\"mid-cap\":{\"path\":\"/\",\"slug\":\"mid-cap\",\"title\":null,\"sasource\":\"\",\"non_theme\":true}},\"title\":\"CACI gets $258M task order from Defense Agencies Initiative program office\",\"lastModified\":\"2022-04-12T08:54:13-04:00\",\"isExclusive\":false,\"status\":\"Active\",\"content\":\"<ul> <li>CACI International (<span class=\\\"ticker-hover-wrapper\\\">NYSE:<a href=\\\"https://seekingalpha.com/symbol/CACI\\\" title=\\\"CACI International Inc\\\">CACI</a></span>) said Tuesday it was <a href=\\\"https://seekingalpha.com/pr/18746187-caci-awarded-258-million-task-order-defense-agencies-initiative-program-office\\\" target=\\\"_blank\\\">awarded a $258M task order</a> to expand its enterprise technology support and<span class=\\\"paywall-full-content\\\"> continue modernization of the Defense Agencies Initiative (DAI) program office's financial management and end-to-end business processes.</span> </li> <li class=\\\"paywall-full-content\\\">The order was awarded under the Defense Logistics Agency's J6 Enterprise Technology Services indefinite delivery, indefinite quantity contract</li> <li class=\\\"paywall-full-content\\\">CACI will support DAI's process areas, improving them with the latest technologies to offer software and DevSecOps at-scale throughout the enterprise.</li> <li class=\\\"paywall-full-content\\\">The order has a 3-year period of performance and will primarily be based in Virginia and the Washington, D.C. metro area.</li> <li class=\\\"paywall-full-content\\\">The latest order consolidates 7 prior contracts into 1 task order that supports 27 Dept. of Defense agencies.</li> </ul>\",\"metered\":true,\"correctionReason\":null},\"relationships\":{\"author\":{\"data\":{\"id\":\"55510976\",\"type\":\"newsAuthorUser\"}},\"sentiments\":{\"data\":[]},\"primaryTickers\":{\"data\":[{\"id\":\"14304\",\"type\":\"tag\"}]},\"secondaryTickers\":{\"data\":[]},\"otherTags\":{\"data\":[]},\"ratingChangeNotice\":{}},\"links\":{\"self\":\"/news/3822657-caci-gets-258m-task-order-from-defense-agencies-initiative-program-office\",\"canonical\":\"https://seekingalpha.com/news/3822657-caci-gets-258m-task-order-from-defense-agencies-initiative-program-office\",\"uriImage\":\"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png\",\"schemaImage\":{\"@type\":\"ImageObject\",\"url\":\"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png\"}}},{\"id\":\"3822656\",\"type\":\"news\",\"attributes\":{\"publishOn\":\"2022-04-12T08:53:44-04:00\",\"isLockedPro\":false,\"commentCount\":0,\"gettyImageUrl\":null,\"themes\":{\"healthcare\":{\"path\":\"/market-news/healthcare\",\"slug\":\"healthcare\",\"title\":\"Healthcare\u00a0\",\"sasource\":\"theme_breadcrumb\",\"non_theme\":false},\"news-metered\":{\"path\":\"/\",\"slug\":\"news-metered\",\"title\":null,\"sasource\":\"\",\"non_theme\":true},\"na-cap\":{\"path\":\"/\",\"slug\":\"na-cap\",\"title\":null,\"sasource\":\"\",\"non_theme\":true}},\"title\":\"UpHealth announces CEO transition plan\",\"lastModified\":\"2022-04-12T08:53:44-04:00\",\"isExclusive\":false,\"status\":\"Active\",\"content\":\"<ul> <li>As a consequence of <a href=\\\"https://seekingalpha.com/news/3706416-cloudbreak-combines-business-with-uphealth-and-uphealth-holdings\\\" target=\\\"_blank\\\">business combination</a> with Cloudbreak Health, UpHealth Holdings and UpHealth (<span class=\\\"ticker-hover-wrapper\\\">NYSE:<a href=\\\"https://seekingalpha.com/symbol/UPH\\\" title=\\\"UpHealth, Inc.\\\">UPH</a></span>), the firm <a href=\\\"https://seekingalpha.com/pr/18746261-uphealth-to-transition-ceo\\\" target=\\\"_blank\\\">notifies</a> that the company<span class=\\\"paywall-full-content\\\"> is conducting a search for a new CEO. </span> </li> <li class=\\\"paywall-full-content\\\">In the interim and through the transition, Dr. Ramesh Balakrishnan will continue in his role and work with the board to ensure a smooth transition until the new CEO takes over.</li> <li class=\\\"paywall-full-content\\\">A search for successor is underway and a short list of qualified healthcare executives has emerged, Dr. Katz said. </li> <li class=\\\"paywall-full-content\\\">The new leader expected to be announced in the coming weeks.</li> <li class=\\\"paywall-full-content\\\">After the new CEO starts, Dr. Balakrishnan will remain with the company in a senior leadership role to be announced in the coming weeks.</li> <li class=\\\"paywall-full-content\\\">Shares of UPH are <span class=\\\"red\\\">down 2.9%</span> PM.</li> </ul>\",\"metered\":true,\"correctionReason\":null},\"relationships\":{\"author\":{\"data\":{\"id\":\"52365730\",\"type\":\"newsAuthorUser\"}},\"sentiments\":{\"data\":[]},\"primaryTickers\":{\"data\":[{\"id\":\"601093\",\"type\":\"tag\"},{\"id\":\"599187\",\"type\":\"tag\"}]},\"secondaryTickers\":{\"data\":[]},\"otherTags\":{\"data\":[]},\"ratingChangeNotice\":{}},\"links\":{\"self\":\"/news/3822656-uphealth-announces-ceo-transition-plan\",\"canonical\":\"https://seekingalpha.com/news/3822656-uphealth-announces-ceo-transition-plan\",\"uriImage\":\"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png\",\"schemaImage\":{\"@type\":\"ImageObject\",\"url\":\"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png\"}}},{\"id\":\"3822654\",\"type\":\"news\",\"attributes\":{\"publishOn\":\"2022-04-12T08:53:27-04:00\",\"isLockedPro\":false,\"commentCount\":0,\"gettyImageUrl\":\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1307666844/image_1307666844.jpg\",\"themes\":{\"healthcare\":{\"path\":\"/market-news/healthcare\",\"slug\":\"healthcare\",\"title\":\"Healthcare\u00a0\",\"sasource\":\"theme_breadcrumb\",\"non_theme\":false},\"news-metered\":{\"path\":\"/\",\"slug\":\"news-metered\",\"title\":null,\"sasource\":\"\",\"non_theme\":true},\"hidden-from-qp\":{\"path\":\"/\",\"slug\":\"hidden-from-qp\",\"title\":null,\"sasource\":\"\",\"non_theme\":true},\"large-cap\":{\"path\":\"/\",\"slug\":\"large-cap\",\"title\":null,\"sasource\":\"\",\"non_theme\":true}},\"title\":\"AbbVie myelofibrosis candidate navitoclax shows improvement in mid-stage trial\",\"lastModified\":\"2022-04-12T08:53:28-04:00\",\"isExclusive\":false,\"status\":\"Active\",\"content\":\"<p><figure class=\\\"getty-figure\\\" data-type=\\\"getty-image\\\"> <picture> <img src=\\\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1307666844/image_1307666844.jpg?io=getty-c-w750\\\" alt=\\\"Abbvie\\\" data-id=\\\"1307666844\\\" data-type=\\\"getty-image\\\" width=\\\"1536px\\\" height=\\\"1178px\\\" srcset=\\\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1307666844/image_1307666844.jpg?io=getty-c-w1536 1536w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1307666844/image_1307666844.jpg?io=getty-c-w1280 1280w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1307666844/image_1307666844.jpg?io=getty-c-w1080 1080w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1307666844/image_1307666844.jpg?io=getty-c-w750 750w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1307666844/image_1307666844.jpg?io=getty-c-w640 640w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1307666844/image_1307666844.jpg?io=getty-c-w480 480w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1307666844/image_1307666844.jpg?io=getty-c-w320 320w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1307666844/image_1307666844.jpg?io=getty-c-w240 240w\\\"> </picture> <figcaption class=\\\"caption\\\" data-type=\\\"getty-image\\\"><p>vzphotos/iStock Editorial via Getty Images</p></figcaption> </figure></p> <ul> <li>Data from a phase 2 trial receiving AbbVie's (<span class=\\\"ticker-hover-wrapper\\\">NYSE:<a href=\\\"https://seekingalpha.com/symbol/ABBV\\\" title=\\\"AbbVie Inc.\\\">ABBV</a></span>) navitoclax in combination with<span class=\\\"paywall-full-content\\\"> Jakafi (ruxolitinib) found that 12 of 32 evaluable patients (38%) </span><a href=\\\"https://seekingalpha.com/pr/18746079-abbvie-presents-positive-investigational-navitoclax-combination-data-in-phase-2-refine-study\\\" target=\\\"_blank\\\" class=\\\"paywall-full-content\\\">had a \u22651 grade improvement in bone marrow fibrosis at any time point in the study</a><span class=\\\"paywall-full-content\\\">.</span> </li> <li class=\\\"paywall-full-content\\\">Patients enrolled in the trial had either progressed while on Incycte's (<a href=\\\"https://seekingalpha.com/symbol/INCY\\\" title=\\\"Incyte Corporation\\\">INCY</a>) Jakafi or had a suboptimal response after at least 12 weeks of treatment.</li> <li class=\\\"paywall-full-content\\\">AbbVie (<a href=\\\"https://seekingalpha.com/symbol/ABBV\\\" title=\\\"AbbVie Inc.\\\">ABBV</a>) previously reported that median overall survival for all patients was not reached.</li> <li class=\\\"paywall-full-content\\\">Results also showed that all patients experienced at least one adverse event, with 44% having a serious one.</li> <li class=\\\"paywall-full-content\\\">Check out why Envision Research <a href=\\\"https://seekingalpha.com/article/4500403-johnson-and-johnson-vs-abbvie-hold\\\" target=\\\"_blank\\\">argues that AbbVie (</a><a href=\\\"https://seekingalpha.com/symbol/ABBV\\\" title=\\\"AbbVie Inc.\\\">ABBV</a>) is a buy.</li> </ul>\",\"metered\":true,\"correctionReason\":null},\"relationships\":{\"author\":{\"data\":{\"id\":\"53161691\",\"type\":\"newsAuthorUser\"}},\"sentiments\":{\"data\":[]},\"primaryTickers\":{\"data\":[{\"id\":\"92371\",\"type\":\"tag\"}]},\"secondaryTickers\":{\"data\":[{\"id\":\"1092\",\"type\":\"tag\"}]},\"otherTags\":{\"data\":[]},\"ratingChangeNotice\":{}},\"links\":{\"self\":\"/news/3822654-abbvie-myelofibrosis-candidate-navitoclax-shows-improvement-in-mid-stage-trial\",\"canonical\":\"https://seekingalpha.com/news/3822654-abbvie-myelofibrosis-candidate-navitoclax-shows-improvement-in-mid-stage-trial\",\"uriImage\":\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1307666844/image_1307666844.jpg?io=getty-c-w750\",\"schemaImage\":[\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1307666844/image_1307666844.jpg?io=getty-c-w1280\",\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1307666844/image_1307666844.jpg?io=getty-c-crop-16-9\",\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1307666844/image_1307666844.jpg?io=getty-c-crop-4-3\"]}},{\"id\":\"3822653\",\"type\":\"news\",\"attributes\":{\"publishOn\":\"2022-04-12T08:51:47-04:00\",\"isLockedPro\":false,\"commentCount\":0,\"gettyImageUrl\":\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/903428504/image_903428504.jpg\",\"themes\":{\"healthcare\":{\"path\":\"/market-news/healthcare\",\"slug\":\"healthcare\",\"title\":\"Healthcare\u00a0\",\"sasource\":\"theme_breadcrumb\",\"non_theme\":false},\"on-the-move\":{\"path\":\"/market-news/on-the-move\",\"slug\":\"on-the-move\",\"title\":\"On the Move\",\"sasource\":\"theme_breadcrumb\",\"non_theme\":false},\"news-metered\":{\"path\":\"/\",\"slug\":\"news-metered\",\"title\":null,\"sasource\":\"\",\"non_theme\":true},\"micro-cap\":{\"path\":\"/\",\"slug\":\"micro-cap\",\"title\":null,\"sasource\":\"\",\"non_theme\":true}},\"title\":\"IM Cannabis stock rises as CEO buys 150K shares\",\"lastModified\":\"2022-04-12T08:51:48-04:00\",\"isExclusive\":false,\"status\":\"Active\",\"content\":\"<p><figure class=\\\"getty-figure\\\" data-type=\\\"getty-image\\\"> <picture> <img src=\\\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/903428504/image_903428504.jpg?io=getty-c-w750\\\" alt=\\\"weed\\\" data-id=\\\"903428504\\\" data-type=\\\"getty-image\\\" width=\\\"1536px\\\" height=\\\"1025px\\\" srcset=\\\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/903428504/image_903428504.jpg?io=getty-c-w1536 1536w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/903428504/image_903428504.jpg?io=getty-c-w1280 1280w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/903428504/image_903428504.jpg?io=getty-c-w1080 1080w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/903428504/image_903428504.jpg?io=getty-c-w750 750w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/903428504/image_903428504.jpg?io=getty-c-w640 640w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/903428504/image_903428504.jpg?io=getty-c-w480 480w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/903428504/image_903428504.jpg?io=getty-c-w320 320w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/903428504/image_903428504.jpg?io=getty-c-w240 240w\\\"> </picture> <figcaption class=\\\"caption\\\" data-type=\\\"getty-image\\\"><p>Yarygin/iStock via Getty Images</p></figcaption> </figure></p> <ul> <li>IM Cannabis (<span class=\\\"ticker-hover-wrapper\\\">NASDAQ:<a href=\\\"https://seekingalpha.com/symbol/IMCC\\\" title=\\\"IM Cannabis Corp.\\\">IMCC</a></span>) shares climbed <span class=\\\"green\\\">~11%</span> Tuesday morning on <a href=\\\"https://seekingalpha.com/pr/18746244-oren-shuster-acquires-common-shares-of-im-cannabis-corp\\\" target=\\\"_blank\\\">disclosure </a>that founder, CEO and<span class=\\\"paywall-full-content\\\"> director Oren Shuster purchased 150K common shares in the capital of IMCC.</span> </li> <li class=\\\"paywall-full-content\\\">The shares were acquired in a series of open market transactions between April 5 and 8, 2022 at an average price of US$2.238/share for an aggregate purchase price of $335.73K. They were purchased for general investment purposes only.</li> <li class=\\\"paywall-full-content\\\">As a result of the transaction, Shuster holds beneficial ownership of 9,285,137 common shares, representing ~13.32% of the issued and outstanding common shares on a non-diluted basis and 14.93% of the common shares on a partially diluted basis.</li> <li class=\\\"paywall-full-content\\\">The resulting change in Shuster's share ownership position is above 2% from his last early warning report (filed on Oct 16, 2019) that showed beneficial ownership of 25.07% of the then issued and outstanding common shares on a non-diluted basis.</li> </ul>\",\"metered\":true,\"correctionReason\":null},\"relationships\":{\"author\":{\"data\":{\"id\":\"54434154\",\"type\":\"newsAuthorUser\"}},\"sentiments\":{\"data\":[]},\"primaryTickers\":{\"data\":[{\"id\":\"603706\",\"type\":\"tag\"}]},\"secondaryTickers\":{\"data\":[]},\"otherTags\":{\"data\":[]},\"ratingChangeNotice\":{}},\"links\":{\"self\":\"/news/3822653-im-cannabis-stock-rises-as-ceo-buys-150k-shares\",\"canonical\":\"https://seekingalpha.com/news/3822653-im-cannabis-stock-rises-as-ceo-buys-150k-shares\",\"uriImage\":\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/903428504/image_903428504.jpg?io=getty-c-w750\",\"schemaImage\":[\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/903428504/image_903428504.jpg?io=getty-c-w1280\",\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/903428504/image_903428504.jpg?io=getty-c-crop-16-9\",\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/903428504/image_903428504.jpg?io=getty-c-crop-4-3\"]}},{\"id\":\"3822652\",\"type\":\"news\",\"attributes\":{\"publishOn\":\"2022-04-12T08:51:45-04:00\",\"isLockedPro\":false,\"commentCount\":0,\"gettyImageUrl\":\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1262837218/image_1262837218.jpg\",\"themes\":{\"consumer\":{\"path\":\"/market-news/consumer\",\"slug\":\"consumer\",\"title\":\"Consumer\u00a0\",\"sasource\":\"theme_breadcrumb\",\"non_theme\":false},\"news-metered\":{\"path\":\"/\",\"slug\":\"news-metered\",\"title\":null,\"sasource\":\"\",\"non_theme\":true},\"small-cap\":{\"path\":\"/\",\"slug\":\"small-cap\",\"title\":null,\"sasource\":\"\",\"non_theme\":true}},\"title\":\"Utz Brands loses bull rating at Credit Suisse with inflation offsets seen lacking\",\"lastModified\":\"2022-04-12T08:51:46-04:00\",\"isExclusive\":false,\"status\":\"Active\",\"content\":\"<p><figure class=\\\"getty-figure\\\" data-type=\\\"getty-image\\\"> <picture> <img src=\\\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1262837218/image_1262837218.jpg?io=getty-c-w750\\\" alt=\\\"Closeup hand pointing pen on blue colour monitor to analyse stock market graph\\\" data-id=\\\"1262837218\\\" data-type=\\\"getty-image\\\" width=\\\"1536px\\\" height=\\\"1024px\\\" srcset=\\\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1262837218/image_1262837218.jpg?io=getty-c-w1536 1536w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1262837218/image_1262837218.jpg?io=getty-c-w1280 1280w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1262837218/image_1262837218.jpg?io=getty-c-w1080 1080w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1262837218/image_1262837218.jpg?io=getty-c-w750 750w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1262837218/image_1262837218.jpg?io=getty-c-w640 640w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1262837218/image_1262837218.jpg?io=getty-c-w480 480w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1262837218/image_1262837218.jpg?io=getty-c-w320 320w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1262837218/image_1262837218.jpg?io=getty-c-w240 240w\\\"> </picture> <figcaption class=\\\"caption\\\" data-type=\\\"getty-image\\\"><p>champc/iStock via Getty Images</p></figcaption> </figure></p> <p>Credit Suisse downgraded Utz Brands (<span class=\\\"ticker-hover-wrapper\\\">NYSE:<a href=\\\"https://seekingalpha.com/symbol/UTZ\\\" title=\\\"Utz Brands, Inc.\\\">UTZ</a></span>) to a Neutral rating after having the snack<span class=\\\"paywall-full-content\\\"> food stock set at Outperform.</span></p> <p class=\\\"paywall-full-content\\\">The firm warned that UTZ does not have enough pricing power for the next wave of inflation. Analyst Robert Moskow pointed out that Utz Brands (UTZ) is only 50% hedged for the year amid rising costs for grains, vegetable oils and fuel.</p> <p class=\\\"paywall-full-content\\\">Moskow and team lower their forecast on UTZ for 2022 EPS to $0.53 from $0.57 and cut the price target to $16.50 from $20, which is based on a trading multiple of 18X the EBITDA estimate.</p> <p class=\\\"paywall-full-content\\\">A positive view is still held on UTZ for the long term with productivity programs expanding. \\\"We continue to view Utz as a relatively well-positioned company in the attractive salty snacks category with significant opportunities for margin expansion,\\\" read the CS update.</p> <p class=\\\"paywall-full-content\\\">Shares of Utz Brands (UTZ) fell <span class=\\\"red\\\">1.59%</span> premarket to $14.27 vs. the <a href=\\\"https://seekingalpha.com/symbol/UTZ/charting\\\" target=\\\"_blank\\\">52-week trading range of $13.50 to $30.09.</a></p>\",\"metered\":true,\"correctionReason\":null},\"relationships\":{\"author\":{\"data\":{\"id\":\"954720\",\"type\":\"newsAuthorUser\"}},\"sentiments\":{\"data\":[]},\"primaryTickers\":{\"data\":[{\"id\":\"605451\",\"type\":\"tag\"}]},\"secondaryTickers\":{\"data\":[]},\"otherTags\":{\"data\":[]},\"ratingChangeNotice\":{}},\"links\":{\"self\":\"/news/3822652-utz-brands-loses-bull-rating-at-credit-suisse-with-inflation-offsets-seen-lacking\",\"canonical\":\"https://seekingalpha.com/news/3822652-utz-brands-loses-bull-rating-at-credit-suisse-with-inflation-offsets-seen-lacking\",\"uriImage\":\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1262837218/image_1262837218.jpg?io=getty-c-w750\",\"schemaImage\":[\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1262837218/image_1262837218.jpg?io=getty-c-w1280\",\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1262837218/image_1262837218.jpg?io=getty-c-crop-16-9\",\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1262837218/image_1262837218.jpg?io=getty-c-crop-4-3\"]}},{\"id\":\"3822649\",\"type\":\"news\",\"attributes\":{\"publishOn\":\"2022-04-12T08:47:45-04:00\",\"isLockedPro\":false,\"commentCount\":0,\"gettyImageUrl\":\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155430254/image_155430254.jpg\",\"themes\":{\"financials\":{\"path\":\"/market-news/financials\",\"slug\":\"financials\",\"title\":\"Financials\u00a0\",\"sasource\":\"theme_breadcrumb\",\"non_theme\":false},\"news-metered\":{\"path\":\"/\",\"slug\":\"news-metered\",\"title\":null,\"sasource\":\"\",\"non_theme\":true},\"small-cap\":{\"path\":\"/\",\"slug\":\"small-cap\",\"title\":null,\"sasource\":\"\",\"non_theme\":true}},\"title\":\"First Financial upgraded to Outperform at Raymond James on loan growth, asset sensitivity\",\"lastModified\":\"2022-04-12T08:47:45-04:00\",\"isExclusive\":false,\"status\":\"Active\",\"content\":\"<p><figure class=\\\"getty-figure\\\" data-type=\\\"getty-image\\\"> <picture> <img src=\\\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155430254/image_155430254.jpg?io=getty-c-w750\\\" alt=\\\"Old Fashioned Bank Sign\\\" data-id=\\\"155430254\\\" data-type=\\\"getty-image\\\" width=\\\"1536px\\\" height=\\\"1170px\\\" srcset=\\\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155430254/image_155430254.jpg?io=getty-c-w1536 1536w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155430254/image_155430254.jpg?io=getty-c-w1280 1280w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155430254/image_155430254.jpg?io=getty-c-w1080 1080w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155430254/image_155430254.jpg?io=getty-c-w750 750w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155430254/image_155430254.jpg?io=getty-c-w640 640w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155430254/image_155430254.jpg?io=getty-c-w480 480w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155430254/image_155430254.jpg?io=getty-c-w320 320w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155430254/image_155430254.jpg?io=getty-c-w240 240w\\\"> </picture> <figcaption class=\\\"caption\\\" data-type=\\\"getty-image\\\"><p>georgeclerk/E+ via Getty Images</p></figcaption> </figure></p> <ul> <li>Raymond James analyst David Long has upgraded First Financial (<span class=\\\"ticker-hover-wrapper\\\">NASDAQ:<a href=\\\"https://seekingalpha.com/symbol/THFF\\\" title=\\\"First Financial Corporation\\\">THFF</a></span>) to Outperform from Market<span class=\\\"paywall-full-content\\\"> Perform, citing potential upside to its asset sensitivity levels as well as organic loan growth.</span> </li> <li class=\\\"paywall-full-content\\\">\\\"A healthy economic backdrop, inflation, and the hiring of a couple veteran commercial bankers should lead to improved loan growth over the net couple of years,\\\" the analyst wrote in a note to clients Tuesday. As a result, he lifted his 2022 loan growth forecast to 4.6% from 3.2%.</li> <li class=\\\"paywall-full-content\\\">Long also pointed to the regional banks' attractive level of excess capital, saying the lender can \\\"leverage its excess capital in an EPS accretive manner via share repurchases or M&amp;A activity,\\\" the note read. This comes in addition to its elevated cash balances, which could be deployed to higher yielding assets in the wake of rising interest rates, according to the note.</li> <li class=\\\"paywall-full-content\\\">Meanwhile, Raymond James' Outperform rating disagrees with both the <a href=\\\"https://seekingalpha.com/symbol/THFF/ratings/quant-ratings\\\" target=\\\"_blank\\\">Quant Rating</a> and the average <a href=\\\"https://seekingalpha.com/symbol/THFF/ratings/sell-side-ratings\\\" target=\\\"_blank\\\">Wall Street Analyst's</a> Hold rating.</li> <li class=\\\"paywall-full-content\\\">In Sept. 2021, First Financial had planned to optimize its <a href=\\\"https://seekingalpha.com/news/3746732-first-financial-accelerates-branch-optimization-plan-leading-to-annual-savings-in-operating-expenses\\\" target=\\\"_blank\\\">banking center network</a>.</li> </ul>\",\"metered\":true,\"correctionReason\":null},\"relationships\":{\"author\":{\"data\":{\"id\":\"54370868\",\"type\":\"newsAuthorUser\"}},\"sentiments\":{\"data\":[]},\"primaryTickers\":{\"data\":[{\"id\":\"9935\",\"type\":\"tag\"}]},\"secondaryTickers\":{\"data\":[]},\"otherTags\":{\"data\":[]},\"ratingChangeNotice\":{}},\"links\":{\"self\":\"/news/3822649-first-financial-upgraded-to-outperform-at-raymond-james-on-loan-growth-asset-sensitivity\",\"canonical\":\"https://seekingalpha.com/news/3822649-first-financial-upgraded-to-outperform-at-raymond-james-on-loan-growth-asset-sensitivity\",\"uriImage\":\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155430254/image_155430254.jpg?io=getty-c-w750\",\"schemaImage\":[\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155430254/image_155430254.jpg?io=getty-c-w1280\",\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155430254/image_155430254.jpg?io=getty-c-crop-16-9\",\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155430254/image_155430254.jpg?io=getty-c-crop-4-3\"]}}],\"included\":[{\"id\":\"52996117\",\"type\":\"newsAuthorUser\",\"attributes\":{\"userId\":52996117,\"image\":{\"small\":\"https://static1.seekingalpha.com/images/users_profile/052/996/117/small_pic.png?t=aa8b9f8abe\",\"medium\":\"https://static1.seekingalpha.com/images/users_profile/052/996/117/medium_pic.png?t=bfe5f7e6c3\",\"big\":\"https://static1.seekingalpha.com/images/users_profile/052/996/117/big_pic.png?t=9e92ef5f05\",\"extra_large\":\"https://static1.seekingalpha.com/images/users_profile/052/996/117/extra_large_pic.png?t=70039c7c2b\"},\"nick\":\"Joshua Fineman, SA News Editor\",\"bio\":\"<p>Josh Fineman covers M&amp;A, special situations and event-driven news at Seeking Alpha. He spent almost 24 years at Bloomberg News with the last 10 years on Bloomberg's First Word/Markets desk. He has also covered finance, fast food industry, music and entertainment and aerospace at Bloomberg. <br><br>He can be reached at joshua@seekingalpha.com\",\"slug\":\"sa-news-team\"},\"links\":{\"self\":\"/user/52996117\",\"profileUrl\":\"/author/sa-editor-joshua-fineman\"}},{\"id\":\"8319\",\"type\":\"tag\",\"attributes\":{\"slug\":\"kkr\",\"name\":\"KKR\",\"company\":\"KKR & Co. Inc.\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"NYSE\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/KKR\"}},{\"id\":\"49447318\",\"type\":\"newsAuthorUser\",\"attributes\":{\"userId\":49447318,\"image\":{\"small\":\"https://static2.seekingalpha.com/images/users_profile/049/447/318/small_pic.png?t=63deb0f79a\",\"medium\":\"https://static2.seekingalpha.com/images/users_profile/049/447/318/medium_pic.png?t=d5bd9a8608\",\"big\":\"https://static2.seekingalpha.com/images/users_profile/049/447/318/big_pic.png?t=17e827a36a\",\"extra_large\":\"https://static2.seekingalpha.com/images/users_profile/049/447/318/extra_large_pic.png?t=b85d9a182d\"},\"nick\":\"Liz Kiesche, SA News Editor\",\"bio\":\"<p>Liz Kiesche covers finance and real estate industries as well as economic news for Seeking Alpha. She has more than 20 years' experience covering business news, and worked on the Headlines/Speed Desk at Bloomberg News for 14 years. Before the Headlines Desk, she was an editor and reporter at Bloomberg covering basic industries.</p><p>She can be contacted at ekiesche@seekingalpha.com or send SA message to SA Editor Liz Kiesche.</p><p>She graduated from Rutgers University and lives in New Jersey with her husband, daughter and dog.</p><p>Hobbies include walking/running, photography, and guitar.</p>\",\"slug\":\"sa-news-team\"},\"links\":{\"self\":\"/user/49447318\",\"profileUrl\":\"/user/49447318/profile\"}},{\"id\":\"11467\",\"type\":\"tag\",\"attributes\":{\"slug\":\"cichf\",\"name\":\"CICHF\",\"company\":\"China Construction Bank Corporation\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"OTCMKTS\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/CICHF\"}},{\"id\":\"15544\",\"type\":\"tag\",\"attributes\":{\"slug\":\"bachy\",\"name\":\"BACHY\",\"company\":\"Bank of China Limited\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"OTCMKTS\",\"fundTypeId\":8,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/BACHY\"}},{\"id\":\"14736\",\"type\":\"tag\",\"attributes\":{\"slug\":\"bachf\",\"name\":\"BACHF\",\"company\":\"Bank of China Limited\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"OTCMKTS\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/BACHF\"}},{\"id\":\"19749\",\"type\":\"tag\",\"attributes\":{\"slug\":\"acgbf\",\"name\":\"ACGBF\",\"company\":\"Agricultural Bank of China Limited\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"OTCMKTS\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/ACGBF\"}},{\"id\":\"19750\",\"type\":\"tag\",\"attributes\":{\"slug\":\"acgby\",\"name\":\"ACGBY\",\"company\":\"Agricultural Bank of China Limited\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"OTCMKTS\",\"fundTypeId\":8,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/ACGBY\"}},{\"id\":\"16040\",\"type\":\"tag\",\"attributes\":{\"slug\":\"cichy\",\"name\":\"CICHY\",\"company\":\"China Construction Bank Corporation\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"OTCMKTS\",\"fundTypeId\":8,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/CICHY\"}},{\"id\":\"14637\",\"type\":\"tag\",\"attributes\":{\"slug\":\"idcbf\",\"name\":\"IDCBF\",\"company\":\"Industrial & Commercial Bank of China Ltd.\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"OTCMKTS\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/IDCBF\"}},{\"id\":\"26230\",\"type\":\"tag\",\"attributes\":{\"slug\":\"idcby\",\"name\":\"IDCBY\",\"company\":\"Industrial & Commercial Bank of China Ltd.\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"OTCMKTS\",\"fundTypeId\":8,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/IDCBY\"}},{\"id\":\"935\",\"type\":\"tag\",\"attributes\":{\"slug\":\"gs\",\"name\":\"GS\",\"company\":\"The Goldman Sachs Group, Inc.\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"NYSE\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/GS\"}},{\"id\":\"906\",\"type\":\"tag\",\"attributes\":{\"slug\":\"bac\",\"name\":\"BAC\",\"company\":\"Bank of America Corporation\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"NYSE\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/BAC\"}},{\"id\":\"907\",\"type\":\"tag\",\"attributes\":{\"slug\":\"jpm\",\"name\":\"JPM\",\"company\":\"JPMorgan Chase & Co.\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"NYSE\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/JPM\"}},{\"id\":\"3936\",\"type\":\"tag\",\"attributes\":{\"slug\":\"pnc\",\"name\":\"PNC\",\"company\":\"The PNC Financial Services Group, Inc.\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"NYSE\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/PNC\"}},{\"id\":\"4974\",\"type\":\"tag\",\"attributes\":{\"slug\":\"bbva\",\"name\":\"BBVA\",\"company\":\"Banco Bilbao Vizcaya Argentaria, S.A.\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"NYSE\",\"fundTypeId\":8,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/BBVA\"}},{\"id\":\"954720\",\"type\":\"newsAuthorUser\",\"attributes\":{\"userId\":954720,\"image\":{\"small\":\"https://static.seekingalpha.com/images/users_profile/000/954/720/small_pic.png?t=c59ef64e67\",\"medium\":\"https://static.seekingalpha.com/images/users_profile/000/954/720/medium_pic.png?t=39a109ae5a\",\"big\":\"https://static.seekingalpha.com/images/users_profile/000/954/720/big_pic.png?t=4747e8d3c8\",\"extra_large\":\"https://static.seekingalpha.com/images/users_profile/000/954/720/extra_large_pic.png?t=a5444f3cf2\"},\"nick\":\"Clark Schultz, SA News Editor\",\"bio\":\"Clark Schultz covers the consumer sector for Seeking Alpha and writes the weekly Stocks to Watch article. He graduated from Washington University in St. Louis with a degree in Economics. He has over 15 years of experience contributing content to major financial websites. In addition, he created the websites <a href=\\\"http://www.moneyrates.com\\\">MoneyRates.com</a> and Savings-Investor.com before selling them to a San Francisco-based company. Clark lives in St. Louis, Missouri with his wife and three kids. Follow on Twitter @ClarkSchultz. E-mail tips/suggestions to Clark@SeekingAlpha.com. <br>\",\"slug\":\"sa-news-team\"},\"links\":{\"self\":\"/user/954720\",\"profileUrl\":\"/author/sa-editor-clark-schultz\"}},{\"id\":\"2977\",\"type\":\"tag\",\"attributes\":{\"slug\":\"ges\",\"name\":\"GES\",\"company\":\"Guess', Inc.\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"NYSE\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/GES\"}},{\"id\":\"51785401\",\"type\":\"newsAuthorUser\",\"attributes\":{\"userId\":51785401,\"image\":{\"small\":\"https://static1.seekingalpha.com/images/users_profile/051/785/401/small_pic.png?t=87753072f2\",\"medium\":\"https://static1.seekingalpha.com/images/users_profile/051/785/401/medium_pic.png?t=00d75bcef2\",\"big\":\"https://static1.seekingalpha.com/images/users_profile/051/785/401/big_pic.png?t=687a2f7b2a\",\"extra_large\":\"https://static1.seekingalpha.com/images/users_profile/051/785/401/extra_large_pic.png?t=512d3983cb\"},\"nick\":\"Manshi Mamtora, CFA, SA News Editor\",\"bio\":\"<p>I am a News Editor- Breaking News Segment at Seeking Alpha and have 5 years experience in financial content writing. I have worked as an Analyst for about 10 years now. I am an avid reader and enjoy studying and learning new things. I completed Chartered Financial Analyst, USA course in 2019. Before joining Seeking Alpha, I worked in the Precious Metal Segment. I stay in Mumbai, India with my family and I am passionate about travelling and reading.</p>\",\"slug\":\"sa-news-team\"},\"links\":{\"self\":\"/user/51785401\",\"profileUrl\":\"/user/51785401/profile\"}},{\"id\":\"26235\",\"type\":\"tag\",\"attributes\":{\"slug\":\"idgc\",\"name\":\"IDGC\",\"company\":\"ID Global Corporation\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"OTCMKTS\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/IDGC\"}},{\"id\":\"54324280\",\"type\":\"newsAuthorUser\",\"attributes\":{\"userId\":54324280,\"image\":{\"small\":\"https://static.seekingalpha.com/images/users_profile/054/324/280/small_pic.png?t=dafc214d5c\",\"medium\":\"https://static.seekingalpha.com/images/users_profile/054/324/280/medium_pic.png?t=f4217e6ad5\",\"big\":\"https://static.seekingalpha.com/images/users_profile/054/324/280/big_pic.png?t=572be39a3d\",\"extra_large\":\"https://static.seekingalpha.com/images/users_profile/054/324/280/extra_large_pic.png?t=666daea558\"},\"nick\":\"Ravikash, SA News Editor\",\"bio\":\"Financial News Editor\",\"slug\":\"sa-news-team\"},\"links\":{\"self\":\"/user/54324280\",\"profileUrl\":\"/user/54324280/profile\"}},{\"id\":\"35310\",\"type\":\"tag\",\"attributes\":{\"slug\":\"vtgn\",\"name\":\"VTGN\",\"company\":\"VistaGen Therapeutics, Inc.\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"NASDAQ\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/VTGN\"}},{\"id\":\"56260577\",\"type\":\"newsAuthorUser\",\"attributes\":{\"userId\":56260577,\"image\":{\"small\":\"https://static1.seekingalpha.com/images/users_profile/056/260/577/small_pic.png?t=6402025585\",\"medium\":\"https://static1.seekingalpha.com/images/users_profile/056/260/577/medium_pic.png?t=e41928eaa6\",\"big\":\"https://static1.seekingalpha.com/images/users_profile/056/260/577/big_pic.png?t=7c393d6471\",\"extra_large\":\"https://static1.seekingalpha.com/images/users_profile/056/260/577/extra_large_pic.png?t=1b9924429d\"},\"nick\":\"Mary Christine Joy, SA News Editor\",\"bio\":\"\",\"slug\":\"sa-news-team\"},\"links\":{\"self\":\"/user/56260577\",\"profileUrl\":\"/user/56260577/profile\"}},{\"id\":\"3390\",\"type\":\"tag\",\"attributes\":{\"slug\":\"trow\",\"name\":\"TROW\",\"company\":\"T. Rowe Price Group, Inc.\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"NASDAQ\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/TROW\"}},{\"id\":\"56228617\",\"type\":\"newsAuthorUser\",\"attributes\":{\"userId\":56228617,\"image\":{\"small\":\"https://static1.seekingalpha.com/images/users_profile/056/228/617/small_pic.png?t=e76550e11d\",\"medium\":\"https://static1.seekingalpha.com/images/users_profile/056/228/617/medium_pic.png?t=afbce12b83\",\"big\":\"https://static1.seekingalpha.com/images/users_profile/056/228/617/big_pic.png?t=5fe636664e\",\"extra_large\":\"https://static1.seekingalpha.com/images/users_profile/056/228/617/extra_large_pic.png?t=e74d383553\"},\"nick\":\"Anuron Mitra, SA News Editor\",\"bio\":\"\",\"slug\":\"sa-news-team\"},\"links\":{\"self\":\"/user/56228617\",\"profileUrl\":\"/user/56228617/profile\"}},{\"id\":\"7350\",\"type\":\"tag\",\"attributes\":{\"slug\":\"cycc\",\"name\":\"CYCC\",\"company\":\"Cyclacel Pharmaceuticals, Inc.\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"NASDAQ\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/CYCC\"}},{\"id\":\"32439325\",\"type\":\"newsAuthorUser\",\"attributes\":{\"userId\":32439325,\"image\":{\"small\":\"https://static1.seekingalpha.com/images/users_profile/032/439/325/small_pic.png?t=07dffe5ebd\",\"medium\":\"https://static1.seekingalpha.com/images/users_profile/032/439/325/medium_pic.png?t=65c4b10abe\",\"big\":\"https://static1.seekingalpha.com/images/users_profile/032/439/325/big_pic.png?t=258e269963\",\"extra_large\":\"https://static1.seekingalpha.com/images/users_profile/032/439/325/extra_large_pic.png?t=8ffc693732\"},\"nick\":\"Niloofer Shaikh, SA News Editor\",\"bio\":\"<p>Niloofer Shaikh is presently a Team Leader - Breaking News at Seeking Alpha. Before joining Seeking Alpha, Niloofer worked with a start-up - Research firm where she worked in the capacity of a Research Associate tracking company events and financial results. Later on moved to fundamental analysis and worked in the capacity of a Senior Financial Analyst. She built consensus model of the assigned companies listed on Nasdaq and NYSE under different sectors. Residing in Mumbai (Commercial Head of India) and a Commerce Graduate with distinction, she pursues her interest in music, travelling across the globe and spending her leisure watching movies. </p>\",\"slug\":\"sa-news-team\"},\"links\":{\"self\":\"/user/32439325\",\"profileUrl\":\"/user/32439325/profile\"}},{\"id\":\"584075\",\"type\":\"tag\",\"attributes\":{\"slug\":\"hyex\",\"name\":\"HYEX\",\"company\":\"Healthy Extracts Inc.\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"OTCMKTS\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/HYEX\"}},{\"id\":\"55510976\",\"type\":\"newsAuthorUser\",\"attributes\":{\"userId\":55510976,\"image\":{\"small\":\"https://static.seekingalpha.com/images/users_profile/055/510/976/small_pic.png?t=f2ab26372b\",\"medium\":\"https://static.seekingalpha.com/images/users_profile/055/510/976/medium_pic.png?t=965b7bf777\",\"big\":\"https://static.seekingalpha.com/images/users_profile/055/510/976/big_pic.png?t=33c4b49cab\",\"extra_large\":\"https://static.seekingalpha.com/images/users_profile/055/510/976/extra_large_pic.png?t=4a72c6f8ec\"},\"nick\":\"Jessica Kuruthukulangara, SA News Editor\",\"bio\":\"<p>Jessica is a news editor at Seeking Alpha, covering breaking news across sectors. She has prior experience covering U.S. consumer and retail companies, various U.S.-listed stocks, cryptocurrency news as well as Indian markets. She has also worked as an editor with a leading Indian business daily.\u00a0</p>\",\"slug\":\"sa-news-team\"},\"links\":{\"self\":\"/user/55510976\",\"profileUrl\":\"/user/55510976/profile\"}},{\"id\":\"14304\",\"type\":\"tag\",\"attributes\":{\"slug\":\"caci\",\"name\":\"CACI\",\"company\":\"CACI International Inc\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"NYSE\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/CACI\"}},{\"id\":\"52365730\",\"type\":\"newsAuthorUser\",\"attributes\":{\"userId\":52365730,\"image\":{\"small\":\"https://static2.seekingalpha.com/images/users_profile/052/365/730/small_pic.png?t=2447e351bd\",\"medium\":\"https://static2.seekingalpha.com/images/users_profile/052/365/730/medium_pic.png?t=a50fa616d2\",\"big\":\"https://static2.seekingalpha.com/images/users_profile/052/365/730/big_pic.png?t=bec5e297e0\",\"extra_large\":\"https://static2.seekingalpha.com/images/users_profile/052/365/730/extra_large_pic.png?t=b6e59321ce\"},\"nick\":\"Meghavi Singh, SA News Editor\",\"bio\":\"<p>I am a News Data Editor (India Team) at Seeking Alpha. Before joining Seeking Alpha, I worked with HSBC Bank for 10+ years in Wealth Management and Regulatory Reporting. Prior to HSBC, I worked with Gridstone Research, a financial research start-up, as Research Associate for a period of 3 years tracking company events and financial results for US Consumer Sector. Based in Mumbai, India, I have done Masters in commerce from Mumbai University.\u00a0 \u00a0</p>\",\"slug\":\"sa-news-team\"},\"links\":{\"self\":\"/user/52365730\",\"profileUrl\":\"/user/52365730/profile\"}},{\"id\":\"601093\",\"type\":\"tag\",\"attributes\":{\"slug\":\"uph\",\"name\":\"UPH\",\"company\":\"UpHealth, Inc.\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"NYSE\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/UPH\"}},{\"id\":\"599187\",\"type\":\"tag\",\"attributes\":{\"slug\":\"uph.ws\",\"name\":\"UPH.WS\",\"company\":\"UpHealth Inc - Warrants (28/02/2026)\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"NYSE\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/UPH.WS\"}},{\"id\":\"53161691\",\"type\":\"newsAuthorUser\",\"attributes\":{\"userId\":53161691,\"image\":{\"small\":\"https://static3.seekingalpha.com/images/users_profile/053/161/691/small_pic.png?t=331daf2fad\",\"medium\":\"https://static3.seekingalpha.com/images/users_profile/053/161/691/medium_pic.png?t=99ff6af40b\",\"big\":\"https://static3.seekingalpha.com/images/users_profile/053/161/691/big_pic.png?t=4e4ae0721e\",\"extra_large\":\"https://static3.seekingalpha.com/images/users_profile/053/161/691/extra_large_pic.png?t=9cd6790a88\"},\"nick\":\"Jonathan Block, SA News Editor\",\"bio\":\"<p>As Seeking Alpha's Health Care News Editor, I oversee breaking and other news affecting multiple health care industries. I also oversee our network of health news writers around the world ensuring their articles are accurate and meet SA standards. I am based in New York City.</p>\",\"slug\":\"sa-news-team\"},\"links\":{\"self\":\"/user/53161691\",\"profileUrl\":\"/user/53161691/profile\"}},{\"id\":\"92371\",\"type\":\"tag\",\"attributes\":{\"slug\":\"abbv\",\"name\":\"ABBV\",\"company\":\"AbbVie Inc.\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"NYSE\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/ABBV\"}},{\"id\":\"1092\",\"type\":\"tag\",\"attributes\":{\"slug\":\"incy\",\"name\":\"INCY\",\"company\":\"Incyte Corporation\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"NASDAQ\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/INCY\"}},{\"id\":\"54434154\",\"type\":\"newsAuthorUser\",\"attributes\":{\"userId\":54434154,\"image\":{\"small\":\"https://static2.seekingalpha.com/images/users_profile/054/434/154/small_pic.png?t=90cc5ca092\",\"medium\":\"https://static2.seekingalpha.com/images/users_profile/054/434/154/medium_pic.png?t=c1aac96ff9\",\"big\":\"https://static2.seekingalpha.com/images/users_profile/054/434/154/big_pic.png?t=787a25bd0b\",\"extra_large\":\"https://static2.seekingalpha.com/images/users_profile/054/434/154/extra_large_pic.png?t=e19e83ad47\"},\"nick\":\"Preeti Singh, SA News Editor\",\"bio\":\"<p>Preeti Singh is a News Editor at Seeking Alpha, covering breaking news for the technology and consumer sector. She has experience covering global corporate financial earnings and producing business insights across various industries. She has completed her Bachelors in Technology with a specialisation in Chemical Engineering from West Bengal University of Technology.</p>\",\"slug\":\"sa-news-team\"},\"links\":{\"self\":\"/user/54434154\",\"profileUrl\":\"/user/54434154/profile\"}},{\"id\":\"603706\",\"type\":\"tag\",\"attributes\":{\"slug\":\"imcc\",\"name\":\"IMCC\",\"company\":\"IM Cannabis Corp.\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"NASDAQ\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/IMCC\"}},{\"id\":\"605451\",\"type\":\"tag\",\"attributes\":{\"slug\":\"utz\",\"name\":\"UTZ\",\"company\":\"Utz Brands, Inc.\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"NYSE\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/UTZ\"}},{\"id\":\"54370868\",\"type\":\"newsAuthorUser\",\"attributes\":{\"userId\":54370868,\"image\":{\"small\":\"https://static.seekingalpha.com/images/users_profile/054/370/868/small_pic.png?t=409000dc8d\",\"medium\":\"https://static.seekingalpha.com/images/users_profile/054/370/868/medium_pic.png?t=416b0c5385\",\"big\":\"https://static.seekingalpha.com/images/users_profile/054/370/868/big_pic.png?t=0e41478de3\",\"extra_large\":\"https://static.seekingalpha.com/images/users_profile/054/370/868/extra_large_pic.png?t=0af51bc415\"},\"nick\":\"Max Gottlich, SA News Editor\",\"bio\":\"Max Gottlich covers financials, cryptos, global macro, insurers, and REITs for Seeking Alpha's breaking news team. He is avid for tracking/studying financial markets, global macro, and central banking. Holds a bachelor's degree in finance from Quinnipiac University. Feel welcome to message him via email at maxg@seekingalpha.com for any tips/suggestions.\u00a0<br>\",\"slug\":\"sa-news-team\"},\"links\":{\"self\":\"/user/54370868\",\"profileUrl\":\"/user/54370868/profile\"}},{\"id\":\"9935\",\"type\":\"tag\",\"attributes\":{\"slug\":\"thff\",\"name\":\"THFF\",\"company\":\"First Financial Corporation\",\"tagKind\":\"Tags::Ticker\",\"equityType\":\"stocks\",\"exchange\":\"NASDAQ\",\"fundTypeId\":0,\"isDefunct\":false,\"isBdc\":false,\"isReit\":false,\"isEtf\":false},\"relationships\":{\"sector\":{},\"subIndustry\":{}},\"links\":{\"self\":\"/symbol/THFF\"}}],\"meta\":{\"page\":{\"title\":\"Breaking Stock Market News\",\"description\":\"Breaking news and real-time stock market updates from Seeking Alpha. Check out the latest investing news and financial headlines.\",\"listTitle\":\"Market News\",\"listDescription\":\"\",\"proStatus\":0,\"size\":14,\"totalPages\":460,\"total\":6428,\"minmaxPublishOn\":{\"min\":1649767665,\"max\":1649768729}},\"ads\":{\"zone\":\"news/news-by-theme/all-market-news/dashboard\"},\"mone\":{\"params\":{\"pu\":\"\"}}}}"